Resultados da pesquisa - Shingo Nakayamada

Refinar resultados
  1. 1
    BAFF- and APRIL-targeted therapy in systemic autoimmune diseases

    BAFF- and APRIL-targeted therapy in systemic autoimmune diseases Por Shingo Nakayamada, Yoshiya Tanaka

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair

    Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair Por Kaoru Yamagata, Shingo Nakayamada, Yoshiya Tanaka

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry

    Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry Por Sae Ochi, Koshiro Sonomoto, Shingo Nakayamada, Yoshiya Tanaka

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Helper T cell diversity and plasticity

    Helper T cell diversity and plasticity Por Shingo Nakayamada, Hayato Takahashi, Yuka Kanno, John J. O’Shea

    Publicado em 2012
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

    Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach Por Yoshiya Tanaka, Yiming Luo, John J. O’Shea, Shingo Nakayamada

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  6. 6
    Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan

    Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan Por Yoshiya Tanaka, Shingo Nakayamada, Kunihiro Yamaoka, Koichiro Ohmura, Shinsuke Yasuda

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry

    Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry Por Koshiro Sonomoto, Shingo Nakayamada, Hiroaki Tanaka, Atsushi Nagayasu, Yoshiya Tanaka

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells

    Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells Por Ippei Miyagawa, Shingo Nakayamada, Kazuhisa Nakano, Kaoru Yamagata, Kei Sakata, Kunihiro Yamaoka, Yoshiya Tanaka

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus

    Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus Por Kei Sakata, Shingo Nakayamada, Yusuke Miyazaki, Satoshi Kubo, Akina Ishii, Kazuhisa Nakano, Yoshiya Tanaka

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting

    Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of t... Por Yusuke Miyazaki, Kazuhisa Nakano, Shingo Nakayamada, Satoshi Kubo, Yoshino Inoue, Yoshihisa Fujino, Yoshiya Tanaka

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Spatial congregation of STAT binding directs selective nuclear architecture during T-cell functional differentiation

    Spatial congregation of STAT binding directs selective nuclear architecture during T-cell functional differentiation Por Ofir Hakim, Myong‐Hee Sung, Shingo Nakayamada, Ty C. Voss, Songjoon Baek, Gordon L. Hager

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Efficacy and Safety of Rituximab in Connective Tissue Disease‐Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy

    Efficacy and Safety of Rituximab in Connective Tissue Disease‐Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy Por Naoaki Ohkubo, Shingo Nakayamada, Shunsuke Fukuyo, Yusuke Miyazaki, Yoshino Inoue, Hiroaki Tanaka, Yasuyuki Todoroki, Yoshiya Tanaka

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    STATs Shape the Active Enhancer Landscape of T Cell Populations

    STATs Shape the Active Enhancer Landscape of T Cell Populations Por Golnaz Vahedi, Hayato Takahashi, Shingo Nakayamada, Hong‐Wei Sun, Vittorio Sartorelli, Yuka Kanno, John J. O’Shea

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis

    Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis Por Ippei Miyagawa, Shingo Nakayamada, Kazuhisa Nakano, Satoshi Kubo, S. Iwata, Yusuke Miyazaki, Maiko Yoshikawa, Hiroko Yoshinari, Yoshiya Tanaka

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Janus kinases to jakinibs: from basic insights to clinical practice

    Janus kinases to jakinibs: from basic insights to clinical practice Por Massimo Gadina, Mimi T. Le, Daniella M. Schwartz, Olli Silvennoinen, Shingo Nakayamada, Kunihiro Yamaoka, John J. O’Shea

    Publicado em 2019
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  16. 16
    Helper T-cell differentiation and plasticity: insights from epigenetics

    Helper T-cell differentiation and plasticity: insights from epigenetics Por Kiyoshi Hirahara, Golnaz Vahedi, Kamran Ghoreschi, Xiang‐Ping Yang, Shingo Nakayamada, Yuka Kanno, John J. O’Shea, Arian Laurence

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  17. 17
    Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis

    Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis Por Katsunori Suzuki, Kazuyoshi Saito, Shizuyo Tsujimura, Shingo Nakayamada, Kunihiro Yamaoka, Norifumi Sawamukai, S. Iwata, Masao Nawata, Kazuhisa Nakano, Yoshiya Tanaka

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis

    Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis Por Yusuke Miyazaki, Shingo Nakayamada, Satoshi Kubo, Kazuhisa Nakano, S. Iwata, Ippei Miyagawa, Xiaoxue Ma, Gulzhan Trimova, Kei Sakata, Yoshiya Tanaka

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease

    Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease Por Satoshi Kubo, Shingo Nakayamada, Jidong Zhao, Maiko Yoshikawa, Yusuke Miyazaki, Aya Nawata, Shintaro Hirata, Kazuhisa Nakano, Kazuyoshi Saito, Yoshiya Tanaka

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System

    Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System Por Satoshi Kubo, Shingo Nakayamada, Kei Sakata, Yukihiro Kitanaga, Xiaoxue Ma, Seunghyun Lee, Akina Ishii, Kaoru Yamagata, Kazuhisa Nakano, Yoshiya Tanaka

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: